Holen Sie sich die Stockscreener-App
29.32
5.01%
1.40
Handel nachbörslich:
29.18
-0.14
-0.48%
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
What Are Hims & Hers Health Stock Investors Overlooking? - Trefis
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Deadline Alert: Hims & Hers Health, Inc. Investors Have - GlobeNewswire
HIMS 1-WEEK DEADLINE ALERT: Hims & Hers Health Investors with Significant Losses Encouraged to Contact Hagens Berman Before Nov. 2, 2026 Deadline in Securities Class Action - PR Newswire
INV DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Innventure, Inc. Investors to Secure Counsel Before Important October 27 Deadline in Securities Class ActionINV - GlobeNewswire Inc.
FTK DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Flotek Industries, Inc. Investors to Secure Counsel Before Important October 26 Deadline in Securities Class ActionFTK - GlobeNewswire Inc.
HIMS FINAL DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class ActionHIMS - GlobeNewswire Inc.
Hims & Hers Health (HIMS) Alert: Securities Class Action Pending, Investors with Losses Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline - GlobeNewswire Inc.
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Millrose Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMRP - GlobeNewswire Inc.
Hims & Hers Health Inc (HIMS) Stock Down 4.9% -- Now Undervalued? GF Score: 75/100 - GuruFocus
Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors - Yahoo Finance
Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors - Zacks Investment Research
Hims & Hers Defends Subscription Practices And Privacy Disclosures Against Lawsuit - Benzinga
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - Carroll County Mirror-Democrat
Hims & Hers Health, Inc. Tokenized Stock (Coinbase) price today, HIMSc to USD live price, marketcap and chart - CoinMarketCap
Hims & Hers Health (HIMS) Facing Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower - The National Law Review
Hims Seeks Dismissal of FTC Suit Over User Data, Subscriptions - Bloomberg.com
Hims & Hers Health, Inc. (HIMS) Stock Forecasts - Yahoo Finance
A New Era for Testosterone Care: Hims Launches New Injectable and Oral TRT Options - Hims & Hers Newsroom
Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date - HIMS investor relations
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock DeclineInvestors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC - GlobeNewswire Inc.
Bragar Eagel & Squire, P.C. Reminds Hims & Hers Health, Inc. Investors of the Upcoming Lead Plaintiff Deadline and Urges Investors to Contact the Firm Before November 2nd - GlobeNewswire Inc.
Hims & Hers Health Inc (HIMS) Shares Surge 3.8% -- What GF Score of 75 Tells Investors - GuruFocus
Hims & Hers Gains as It Launches Men’s Weight-Loss Care in Germany - Yahoo Finance
Hims & Hers Health Jumps 6.2% Amid Sector-Wide Rally - AlphaStreet
What's Next for Hims & Hers Health, Inc. Shareholders After 14.73% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline - Morningstar
Hims & Hers gains after German launch - Seeking Alpha
Hims & Hers Health launches online weight management service for men in Germany - Reuters
Hims & Hers Health launches online weight management service for men in Germany - Yahoo Finance Singapore
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Hims Is Reaching the Three Million Member Milestone - The Motley Fool
HIMS DEADLINE: ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class ActionHIMS - GlobeNewswire Inc.
What Are Hims & Hers Health Stock Bears Missing? - Trefis
Hims & Hers Health: The Lollapalooza Effect Of GLP-1s (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Inc (HIMS) Stock Down 4.5% -- Now Undervalued? GF Score: 75/100 - GuruFocus
ROSEN, LEADING INVESTOR COUNSEL, Encourages Millrose Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMRP - GlobeNewswire Inc.
HIMS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionHIMS - GlobeNewswire Inc.
What Does Hims & Hers Health (HIMS) Expansion Into The UK And Australia Mean? - Yahoo Finance
Hims & Hers Health (HIMS) Alert: Securities Class Action Filed, Investors with Losses Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline - PR Newswire
How Is Hims & Hers Health, Inc. (NYSE:HIMS) Reshaping Its Business? - Kalkine Media
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Zacks Investment Research
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - The Killeen Daily Herald
Kaplan Fox & Kilsheimer LLP Encourages Hims & Hers Health, Inc - The National Law Review
Hims & Hers Health rises as HHS moves ahead with plan for compounding peptides - Seeking Alpha
US FDA takes step to change peptide compounding policy - Reuters
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
Our Commitment to Independent, Clinician-Led Care - Hims & Hers Newsroom
0.05%
6.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):